Literature DB >> 30055267

Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease.

Byron P Vaughn1, Kevin M Rank1, Alexander Khoruts2.   

Abstract

Fecal microbiota transplantation was originally introduced as a method to repair intestinal microbiota following failure of multiple treatments of recurrent Clostridiumdifficile infection with antibiotics. However, it is hypothesized that intestinal dysbiosis may contribute to the pathogenesis of many diseases, especially those involving the gastrointestinal tract. Therefore, fecal microbiota transplantation is increasingly being explored as a potential treatment that aims to optimize microbiota composition and functionality. Here, we review the current state of fecal microbiota transplantation development and applications in conditions of greatest interest to a gastroenterologist.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clostridium difficile Infection; Fecal Microbiota Transplantation; Inflammatory Bowel Disease; Irritable Bowel Syndrome; Liver Disease; Pathobiome

Mesh:

Year:  2018        PMID: 30055267     DOI: 10.1016/j.cgh.2018.07.026

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  15 in total

1.  Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.

Authors:  Lanfeng Xue; Zhiliang Deng; Wenhui Luo; Xingxiang He; Yu Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-07-04       Impact factor: 6.073

2.  AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders.

Authors:  Geoffrey A Preidis; Adam V Weizman; Purna C Kashyap; Rebecca L Morgan
Journal:  Gastroenterology       Date:  2020-06-09       Impact factor: 22.682

3.  Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis.

Authors:  Kanchana Myneedu; Abhizith Deoker; Max J Schmulson; Mohammad Bashashati
Journal:  United European Gastroenterol J       Date:  2019-07-30       Impact factor: 4.623

4.  An ecological framework to understand the efficacy of fecal microbiota transplantation.

Authors:  Yandong Xiao; Marco Tulio Angulo; Songyang Lao; Scott T Weiss; Yang-Yu Liu
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

Review 5.  Carcinogenesis and Metastasis in Liver: Cell Physiological Basis.

Authors:  Anna Rossetto; Valli De Re; Agostino Steffan; Matteo Ravaioli; Gianmaria Miolo; Patrizia Leone; Vito Racanelli; Alessandro Uzzau; Umberto Baccarani; Matteo Cescon
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

Review 6.  Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.

Authors:  Yoshiyuki Mishima; Ryan Balfour Sartor
Journal:  J Gastroenterol       Date:  2019-09-03       Impact factor: 7.527

Review 7.  The Role of Intestinal Flora in the Regulation of Bone Homeostasis.

Authors:  Chengxiang Li; Guofu Pi; Feng Li
Journal:  Front Cell Infect Microbiol       Date:  2021-03-12       Impact factor: 5.293

8.  Patients and physicians' attitudes change on fecal microbiota transplantation for inflammatory bowel disease over the past 3 years.

Authors:  Yujie Zhang; Xianmin Xue; Song Su; He Zhou; Yirong Jin; Yanting Shi; Junchao Lin; Jiayao Wang; Xiaofei Li; Gang Yang; Jessica R Philpott; Jie Liang
Journal:  Ann Transl Med       Date:  2021-11

Review 9.  Seven facts and five initiatives for gut microbiome research.

Authors:  Danyi Li; Chunhui Gao; Faming Zhang; Ruifu Yang; Canhui Lan; Yonghui Ma; Jun Wang
Journal:  Protein Cell       Date:  2020-06       Impact factor: 14.870

Review 10.  The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge.

Authors:  Amir Mari; Fadi Abu Baker; Mahmud Mahamid; Wisam Sbeit; Tawfik Khoury
Journal:  J Clin Med       Date:  2020-03-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.